Volume 23, Number 1—January 2017
Letter
Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited
Table
Patient no. | Isolate no. | Patient age | Outcome | Capsular serotype | Sequence type | covR/S mutation |
---|---|---|---|---|---|---|
1 | BSU286 | 65 y | Died | II | 22 | – |
2 | BSU287 | 71 y | Survived | Ia | 23 | – |
3 | BSU288 | 46 y | Died | V | 1 | – |
4 | BSU289 | 46 y | Survived | IV | 397 | – |
5 | BSU290 | 43 y | Survived | V | 1 | – |
6 | BSU291 | 35 y | Died | III | 19 | – |
7 | BSU292 | 76 y | Survived | V | 1 | – |
8 | BSU293 | 48 y | Survived | Ia | 23 | – |
9 | BSU294 | 61 y | Died | V | 1 | – |
10 | BSU295 | 45 y | Survived | V | 1 | – |
11 | BSU296 | 63 y | Died | Ib | 8 | – |
12 | BSU297 | 0 d | Survived | Ia | 23 | – |
13 | BSU298 | 70 y | Survived | V | 1 | – |
14 | BSU299 | 60 y | Survived | V | 1 | – |
15 | BSU300 | 73 y | Survived | V | 1 | – |
16 | BSU301 | 66 y | Died | III | 17 | – |
17 | BSU302 | 2 mo | Survived | III | 17 | – |
18 | BSU303 | 94 y | Survived | V | 23 | Yes |
19 | BSU304 | 1 mo | Died | Ia | 23 | – |
20 | BSU305 | 34 y | Survived | V | 1 | – |
21 | BSU306 | 59 y | Survived | IV | 2 | – |
22 |
BSU307 |
79 y |
Died |
Ia |
88 |
– |
23 (4) | BSU865, VS | 38 y | Survived | II | 19 | – |
BSU866, BC |
– |
– |
– |
|||
24 | BSU869 | 32 y | Died | Ib | 8 | – |
25 |
BSU870 |
53 y |
Survived |
Ia |
23 |
– |
Control (3) | BSU871 | 50 y | Survived | Ib | 8 | Yes |
*BC, blood culture; GBS, group B Streptococcus; STSS, streptococcal toxic shock syndrome; VS, vaginal swab; –, not found.
1These authors contributed equally to this article.
Page created: December 16, 2016
Page updated: December 16, 2016
Page reviewed: December 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.